Alliance Pharma plc (LON:APH – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 39.04 ($0.49) and traded as low as GBX 37.10 ($0.46). Alliance Pharma shares last traded at GBX 37.25 ($0.46), with a volume of 441,309 shares changing hands.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada lowered their target price on Alliance Pharma from GBX 65 ($0.81) to GBX 60 ($0.75) and set an “outperform” rating on the stock in a research report on Wednesday, January 31st.
Check Out Our Latest Stock Report on APH
Alliance Pharma Price Performance
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Recommended Stories
- Five stocks we like better than Alliance Pharma
- Industrial Products Stocks Investing
- United Airlines Soars on Earnings Beat
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.